NO20070931L - Fremgangsmate for strukturell karakterisering av et rekombinant polyklonelt protein eller en polykonell celle-linje. - Google Patents

Fremgangsmate for strukturell karakterisering av et rekombinant polyklonelt protein eller en polykonell celle-linje.

Info

Publication number
NO20070931L
NO20070931L NO20070931A NO20070931A NO20070931L NO 20070931 L NO20070931 L NO 20070931L NO 20070931 A NO20070931 A NO 20070931A NO 20070931 A NO20070931 A NO 20070931A NO 20070931 L NO20070931 L NO 20070931L
Authority
NO
Norway
Prior art keywords
polyclonal
cell line
structural characterization
recombinant
protein
Prior art date
Application number
NO20070931A
Other languages
English (en)
Norwegian (no)
Inventor
Peter Sejer Andersen
Soren Kofoed Rasmussen
Lone Kjaer Rasmussen
Torben Frandsen
Original Assignee
Symphogen As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symphogen As filed Critical Symphogen As
Publication of NO20070931L publication Critical patent/NO20070931L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/96—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation using ion-exchange
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Document Processing Apparatus (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20070931A 2004-07-20 2007-02-19 Fremgangsmate for strukturell karakterisering av et rekombinant polyklonelt protein eller en polykonell celle-linje. NO20070931L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200401133 2004-07-20
DKPA200401991 2004-12-22
PCT/DK2005/000504 WO2006007853A2 (en) 2004-07-20 2005-07-20 A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line

Publications (1)

Publication Number Publication Date
NO20070931L true NO20070931L (no) 2007-04-17

Family

ID=35427551

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070931A NO20070931L (no) 2004-07-20 2007-02-19 Fremgangsmate for strukturell karakterisering av et rekombinant polyklonelt protein eller en polykonell celle-linje.

Country Status (19)

Country Link
US (2) US8288109B2 (pt)
EP (2) EP1787126B1 (pt)
JP (1) JP4870667B2 (pt)
KR (1) KR101319848B1 (pt)
AT (2) ATE443870T1 (pt)
AU (1) AU2005263334C1 (pt)
BR (1) BRPI0513714A (pt)
CA (1) CA2574146C (pt)
DE (1) DE602005016818D1 (pt)
DK (2) DK2053408T3 (pt)
ES (2) ES2381531T3 (pt)
HK (2) HK1101043A1 (pt)
IL (2) IL180169A (pt)
MX (1) MX2007000551A (pt)
NO (1) NO20070931L (pt)
NZ (1) NZ552264A (pt)
PL (2) PL1787126T3 (pt)
RU (1) RU2426795C2 (pt)
WO (1) WO2006007853A2 (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4589914B2 (ja) 2003-01-07 2010-12-01 シムフォゲン・アクティーゼルスカブ 組換え型ポリクローナルタンパク質の製造方法
TWI333977B (en) * 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
EP1787126B1 (en) 2004-07-20 2009-09-23 Symphogen A/S A procedure for characterization of a polyclonal cell line
CA2574062A1 (en) 2004-07-20 2006-01-26 Symphogen A/S Anti-rhesus d recombinant polyclonal antibody and methods of manufacture
JP2009518320A (ja) 2005-12-05 2009-05-07 シュムフォウエン アクティーゼルスカブ 抗オルトポックスウイルス組換えポリクローナル抗体
US8338376B2 (en) 2006-10-20 2012-12-25 Biogen Idec Ma Inc. Compositions comprising variant LT-B-R-IG fusion proteins
KR20090118993A (ko) * 2007-03-01 2009-11-18 심포젠 에이/에스 동족체 항체 클로닝 방법
BRPI0808551B1 (pt) * 2007-03-01 2022-04-05 Symphogen A/S Composições de anticorpo para o receptor do fator de crescimento antiepidérmico recombinante, molécula de ligação bi-específica e composição farmacêutica que os compreende
MX2009009226A (es) 2007-03-06 2009-10-28 Symphogen As Anticuerpos recombinantes para el tratamiento de infecciones con el virus respiratorio sincitial.
EP2139509A2 (en) * 2007-03-15 2010-01-06 Biogen Idec MA, Inc. Treatment of autoimmune disorders
NZ581316A (en) 2007-05-25 2012-02-24 Symphogen As Method for manufacturing a recombinant polyclonal protein
JP2008289483A (ja) * 2007-05-25 2008-12-04 Symphogen As 真核生物系において発現可能な形質転換体のスクリーニング
BRPI0817079A2 (pt) * 2007-09-07 2016-10-11 Symphogen As processos para fabricação recombinante de anticorpos anti-rsv
CN101874207A (zh) * 2007-11-22 2010-10-27 西福根有限公司 用于表征重组多克隆蛋白质的方法
EP2280998A1 (en) * 2008-04-23 2011-02-09 Symphogen A/S Methods for manufacturing a polyclonal protein
BRPI0918768B1 (pt) 2008-08-29 2022-08-30 Symphogen A/S Composições de anticorpo recombinante de antireceptor do fator de crescimento epidérmico
CA2735020A1 (en) * 2008-08-29 2010-03-04 Symphogen A/S Method for cloning avian-derived antibodies
WO2011028961A2 (en) 2009-09-04 2011-03-10 Xoma Technology Ltd. Anti-botulism antibody coformulations
US20120264155A1 (en) * 2009-10-09 2012-10-18 Symphogen A/S Multiplex Quantitation of Individual Recombinant Proteins in a Mixture by Signature Peptides and Mass Spectrometry
MX336196B (es) * 2010-04-15 2016-01-11 Abbvie Inc Proteinas de union a amiloide beta.
CA2816520C (en) 2010-11-01 2017-11-21 Symphogen A/S Anti-her3 antibodies and compositions
EP2953970A4 (en) 2013-02-08 2016-06-29 Misfolding Diagnostics Inc TRANSTYRETIN ANTIBODIES AND USES THEREOF
UY35517A (es) 2013-04-04 2014-10-31 Mabxience S A Un procedimiento para aumentar la formación de ácido piroglutamico de una proteína
WO2015093925A1 (es) * 2013-12-19 2015-06-25 CASTRO ALDRETE, Jorge Isaac Método de producción de anticuerpos específicos
TW201623331A (zh) * 2014-03-12 2016-07-01 普羅帝納生物科學公司 抗黑色素瘤細胞黏著分子（ｍｃａｍ）抗體類及使用彼等之相關方法
US11680948B2 (en) 2016-08-12 2023-06-20 Abreos Biosciences, Inc. Detection and quantification of natalizumab
WO2019243626A1 (en) * 2018-06-22 2019-12-26 Genmab A/S Method for producing a controlled mixture of two or more different antibodies
CN112816595A (zh) * 2021-01-06 2021-05-18 海默斯（重庆）医学生物技术有限公司 一种重组角蛋白液体制剂及其纯度检测方法

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002413A1 (en) 1983-11-28 1985-06-06 The Board Of Trustees Of The Leland Stanford Jr. U HUMAN MONOCLONAL ANTIBODY AGAINST Rh(D) ANTIGEN AND ITS USES
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
CA1293460C (en) 1985-10-07 1991-12-24 Brian Lee Sauer Site-specific recombination of dna in yeast
US5126130A (en) * 1986-11-24 1992-06-30 The Childrens Hospital Incorporated Monoclonal antibodies reactive with specific antigenic sites on human cytomegalovirus glycoprotein a
GB8722018D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722019D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
GB8722020D0 (en) 1987-09-18 1987-10-28 Central Blood Lab Authority Human anti-rh(d)monoclonal antibodies
JP2919890B2 (ja) 1988-11-11 1999-07-19 メディカル リサーチ カウンスル 単一ドメインリガンド、そのリガンドからなる受容体、その製造方法、ならびにそのリガンドおよび受容体の使用
GB8906129D0 (en) 1989-03-17 1989-05-04 Central Blood Lab Authority Pharmaceutical preparations
GB8919761D0 (en) 1989-09-01 1989-10-18 Central Blood Lab Authority Chemical compounds
WO1992015694A1 (en) 1991-03-08 1992-09-17 The Salk Institute For Biological Studies Flp-mediated gene modification in mammalian cells, and compositions and cells useful therefor
US5837268A (en) 1991-10-16 1998-11-17 University Of Saskatchewan GnRH-leukotoxin chimeras
US5252216A (en) * 1992-03-24 1993-10-12 Smithkline Beecham Corporation Protein purification
DE69328135D1 (de) 1992-06-26 2000-04-27 Aetsrn Menschliche monoklonale Antikörper gegen Rhesus D und Zellinien die diese produzieren
US5538848A (en) * 1994-11-16 1996-07-23 Applied Biosystems Division, Perkin-Elmer Corp. Method for detecting nucleic acid amplification using self-quenching fluorescence probe
ATE243745T1 (de) 1994-01-31 2003-07-15 Univ Boston Bibliotheken aus polyklonalen antikörpern
FR2724182B1 (fr) * 1994-09-02 1996-12-13 Pasteur Institut Obtention d'un anticorps monoclonal recombinant a partir d'un anticorps monoclonal humain anti-rhesus d, sa production en cellules d'insecte, et ses utilisations
US6111166A (en) 1994-09-19 2000-08-29 Medarex, Incorporated Transgenic mice expressing human Fcα and β receptors
KR100361449B1 (ko) 1996-06-24 2003-01-24 체트엘베 바이오플라스마 아게 리서스D항원들(RhesusDantigens)에특정적인항원결합구조들을형성할수있는폴리펩티드들,그것들을인코딩한DNA,그리고그것들의제조방법및용도
US6255455B1 (en) * 1996-10-11 2001-07-03 The Trustees Of The University Of Pennsylvania Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof
US5876925A (en) * 1996-10-11 1999-03-02 The Trustees Of The University Of Pennsylvania Magnetically activated cell sorting for production of proteins
CN1175111C (zh) 1997-03-14 2004-11-10 艾德药品公司 将基因整合至哺乳动物细胞特定位点的方法及所用载体
JPH11174038A (ja) * 1997-12-10 1999-07-02 Tosoh Corp 蛋白質の分離精製法
WO2000011155A1 (en) 1998-08-19 2000-03-02 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for genomic modification
US20020155114A1 (en) * 1998-08-31 2002-10-24 James D. Marks Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins
JP2003504638A (ja) * 1999-07-16 2003-02-04 ヒューマン ジノーム サイエンシーズ， インコーポレイテッド 赤外分光法に応じたリアルタイムのインサイチュバイオマニュファクチャリングプロセスのモニタリングおよび制御
CA2379115C (en) 1999-07-23 2011-04-26 The Regents Of The University Of California Dna recombination in eukaryotic cells by the bacteriophage phic31 recombination system
EP1106625A1 (en) 1999-11-17 2001-06-13 ZLB Bioplasma AG Rhesus D specific peptide sequences
CA2400484A1 (en) 2000-02-08 2001-08-16 The Regents Of The University Of Michigan Protein separation and display
AU2001234893A1 (en) 2000-02-08 2001-08-20 The Regents Of The University Of Michigan Protein mapping
US7069151B2 (en) 2000-02-08 2006-06-27 Regents Of The University Of Michigan Mapping of differential display of proteins
WO2001089563A1 (en) 2000-05-26 2001-11-29 Symphogen A/S Recombinant or purified polyclonal antibodies for treating allergy
US6610472B1 (en) 2000-10-31 2003-08-26 Genetastix Corporation Assembly and screening of highly complex and fully human antibody repertoire in yeast
CA2430080A1 (en) * 2000-11-28 2002-06-06 Applied Molecular Evolution, Inc. Eukaryotic expression libraries based on double lox recombination and methods of use
EP1739424B1 (en) * 2000-12-26 2011-08-24 The Institute for Systems Biology Rapid and quantitative proteome anaysis and related methods
AU2002367582A1 (en) * 2001-07-17 2003-09-29 Ciphergen Biosystems, Inc. Latex based adsorbent chip
EP1456667B2 (en) * 2001-12-08 2010-01-20 Micromass UK Limited Method of mass spectrometry
US20040033591A1 (en) 2002-05-31 2004-02-19 The Regents Of The University Of Michigan Automated protein analysis system
PT2314629E (pt) * 2002-07-18 2014-01-22 Merus B V Produção recombinante de misturas de anticorpos
JP2004101477A (ja) * 2002-09-12 2004-04-02 Yoshio Yamauchi ２次元高速液体クロマトグラフ装置及びそれを用いた蛋白質分析装置
AU2003284227A1 (en) 2002-10-15 2004-05-04 The Regents Of The University Of Michigan Multidimensional protein separation system
JP4589914B2 (ja) * 2003-01-07 2010-12-01 シムフォゲン・アクティーゼルスカブ 組換え型ポリクローナルタンパク質の製造方法
US20060275766A1 (en) * 2003-01-07 2006-12-07 Haurum John S Method for manufacturing recombinant polyclonal proteins
TWI333977B (en) 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
EP1787126B1 (en) 2004-07-20 2009-09-23 Symphogen A/S A procedure for characterization of a polyclonal cell line
CA2574062A1 (en) 2004-07-20 2006-01-26 Symphogen A/S Anti-rhesus d recombinant polyclonal antibody and methods of manufacture
JP2009518320A (ja) 2005-12-05 2009-05-07 シュムフォウエン アクティーゼルスカブ 抗オルトポックスウイルス組換えポリクローナル抗体
KR20080113223A (ko) 2006-03-06 2008-12-29 심포젠 에이/에스 호흡기세포 융합 바이러스 감염 치료용 재조합 폴리클로날 항체
CN101874207A (zh) 2007-11-22 2010-10-27 西福根有限公司 用于表征重组多克隆蛋白质的方法

Also Published As

Publication number Publication date
ATE443870T1 (de) 2009-10-15
HK1101043A1 (en) 2007-10-05
US20080131882A1 (en) 2008-06-05
US9029091B2 (en) 2015-05-12
CA2574146C (en) 2015-06-30
MX2007000551A (es) 2007-03-30
PL1787126T3 (pl) 2010-03-31
EP1787126A2 (en) 2007-05-23
EP2053408B1 (en) 2012-03-07
ATE548657T1 (de) 2012-03-15
AU2005263334A1 (en) 2006-01-26
DK1787126T3 (da) 2009-12-21
CA2574146A1 (en) 2006-01-26
PL2053408T3 (pl) 2012-08-31
AU2005263334B2 (en) 2010-08-05
EP2053408A2 (en) 2009-04-29
NZ552264A (en) 2010-03-26
WO2006007853A3 (en) 2006-05-18
ES2332524T3 (es) 2010-02-08
DK2053408T3 (da) 2012-06-04
RU2426795C2 (ru) 2011-08-20
KR101319848B1 (ko) 2013-10-18
DE602005016818D1 (de) 2009-11-05
JP4870667B2 (ja) 2012-02-08
RU2007106050A (ru) 2008-08-27
AU2005263334C1 (en) 2011-01-20
EP2053408A3 (en) 2009-07-29
US8288109B2 (en) 2012-10-16
IL203017A (en) 2013-08-29
IL180169A0 (en) 2007-06-03
US20130203063A1 (en) 2013-08-08
BRPI0513714A (pt) 2008-05-13
IL180169A (en) 2011-04-28
JP2008506960A (ja) 2008-03-06
KR20070032078A (ko) 2007-03-20
HK1133076A1 (en) 2010-03-12
ES2381531T3 (es) 2012-05-29
EP1787126B1 (en) 2009-09-23
WO2006007853A2 (en) 2006-01-26

Similar Documents

Publication Publication Date Title
NO20070931L (no) Fremgangsmate for strukturell karakterisering av et rekombinant polyklonelt protein eller en polykonell celle-linje.
Sander et al. A new method to bind allergens for the measurement of specific IgE antibodies
BRPI0507433C1 (pt) anticorpo monoclonal recombinante ou sua parte de ligação ao antígeno, composição, ácido nucleico isolado, vetor de expressão, e, kit
MX2010005377A (es) Metodo para caracterizacion de proteina policlonal recombinante.
NO963371L (no) Hematopoietisk protein samt materialer og fremgangsmåter for fremstilling av det
ATE500331T1 (de) Verfahren zur gleichzeitigen herstellung von multiplen proteinen; vektoren und zellen, die hierfür verwendung finden
Rogge et al. Assembly of nucleosomal arrays from recombinant core histones and nucleosome positioning DNA
DE602005013947D1 (de) Antikörper gegen hundepankreaslipase
ATE521695T1 (de) Zirkuläres dna-molekül mit einem konditionalen replikationsursprung, verfahren zur herstellung davon und ihre verwendung in der gentherapie
Peterson et al. Antibodies to phosphatidylserine/prothrombin complex in antiphospholipid syndrome: analytical and clinical perspectives
Kosmoliaptsis et al. Improved Luminex-based human leukocyte antigen-specific antibody screening using dithiothreitol-treated sera
Mendrick et al. Monoclonal antibodies against rat glomerular antigens: production and specificity.
Wang et al. Development of antibody arrays for monoclonal antibody higher order structure analysis
DE602005022757D1 (de) Verwendung von endosialinbindenden proteinen zum isolieren endosialinpositiver zellen
DE69835047D1 (de) Schaumproteine, monoklonale Antikörper dagegen, und deren Verwendungen
SE0003566D0 (sv) A method for the quantitative determination of one or more compounds
Mehand et al. Estimation of analyte concentration by surface plasmon resonance-based biosensing using parameter identification techniques
Huang et al. Synergistic actions of histamine-releasing factor and histamine releasing factor-reactive IgE in chronic urticaria
ATE532796T1 (de) Immunassays zur spezifischen bestimmung von scca- isoformen
ATE423133T1 (de) Verfahren und materialien zur behandlung von entzündungen unter verwendung eines polypeptides das einen eigenen-c5 aminosaüresegment und einen nicht-eigenen aminosaüresegment enthält
Altinier et al. An IgE multiple myeloma: contradictory findings in clinical laboratory testing
Kelner et al. Analytical strategy for biopharmaceutical development
WO2006089002A3 (en) Method for high throughput screening for antibodies and proteins inducing apoptosis
Diaz-Barreiro et al. Oxidation-sensitive cysteines drive IL-38 amyloid formation
Larsson et al. Capillary electrophoresis for monitoring the effects of plasmapheresis: A feasibility study

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application